Identification of protein partners of the human immunodeficiency virus 1 tat/rev exon 3 leads to the discovery of a new HIV-1 splicing regulator, protein hnRNP K

RNA Biology

Volumn 8, Issue 2, 2011, Pages

  Marchand, Virginie ^a,c   Santerre, Maryline ^a   Aigueperse, Christelle ^a   Fouillen, Laetitia ^b   Saliou, Jean Michel ^b   Van Dorsselaer, Alain ^b   Sanglier Cianférani, Sarah ^b   Branlant, Christiane ^a   Motorin, Yuri ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE RECHERCHES SUBATOMIQUES   (France)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

hnRNP K; Mass spectrometry; Nucleolin; RNP affinity chromatography; Splicing regulation; Virus HIV 1

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; DNA BINDING PROTEIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ELONGATION FACTOR 1ALPHA; GLYCOGEN PHOSPHORYLASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; HNRNP A1; HNRNP K PROTEIN; INTERLEUKIN ENHANCER BINDING FACTOR 2; INTERLEUKIN ENHANCER BINDING FACTOR 3; KARYOPHERIN; NEF PROTEIN; NUCLEOLIN; NUCLEOPHOSMIN; RAN PROTEIN; REV PROTEIN; RNA HELICASE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN; VIRUS RNA; PHOSPHOPROTEIN; RNA BINDING PROTEIN; RNA PRECURSOR;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; RNA SPLICING; VIROGENESIS; ALTERNATIVE RNA SPLICING; BIOSYNTHESIS; CELL NUCLEUS; EXON; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ULTRASTRUCTURE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALTERNATIVE SPLICING; CELL NUCLEUS; EXONS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HIV-1; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHOSPHOPROTEINS; PROTEIN BINDING; RNA PRECURSORS; RNA SPLICING; RNA, VIRAL; RNA-BINDING PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79954475530     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna/8.2.13984     Document Type: Article

References (72)

1. Purcell DF, Martin MA. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication and infectivity. J Virol 1993; 67:6365-78. (Pubitemid 23309100)
2. Stoltzfus MC. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication. Adv Virus Res 2009; 74:1-40.
3. Nekhai S, Jeang KT. Transcriptional and post-transcriptional regulation of HIV-1 gene expression: role of cellular factors for Tat and Rev. Future Microbiol 2006; 1:417-26.
4. Cullen BR. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 1998; 93:685-92. (Pubitemid 28257576)
5. Cullen BR. Nuclear mRNA export: insights from virology. Trends Biochem Sci 2003; 28:419-24. (Pubitemid 36976744)
6. Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995; 268:429-31.
7. Jacquenet S, Mereau A, Bilodeau PS, Damier L, Stoltzfus CM, Branlant C. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem 2001; 276:40464-75.
8. Marchand V, Mereau A, Jacquenet S, Thomas D, Mougin A, Gattoni R, et al. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. J Mol Biol 2002; 323:629-52. (Pubitemid 36160221)
9. Hallay H, Locker N, Ayadi L, Ropers D, Guittet E, Branlant C. Biochemical and NMR study on the competition between proteins SC35, SRp40 and heterogeneous nuclear ribonucleoprotein A1 at the HIV-1 Tat exon 2 splicing site. J Biol Chem 2006; 281:37159-74. (Pubitemid 46042186)
10. Staffa A, Cochrane A. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol Cell Biol 1995; 15:4597-605.
11. Si ZH, Rauch D, Stoltzfus CM. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly. Mol Cell Biol 1998; 18:5404-13. (Pubitemid 28388123)
12. Damgaard CK, Tange TO, Kjems J. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA 2002; 8:1401-15. (Pubitemid 35332964)
13. Tange TO, Damgaard CK, Guth S, Valcarcel J, Kjems J. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. EMBO J 2001; 20:5748-58. (Pubitemid 33014352)
14. Caputi M, Mayeda A, Krainer AR, Zahler AM. hnRNP A/B proteins are required for inhibition of HIV-1 premRNA splicing. EMBO J 1999; 18:4060-7. (Pubitemid 29335858)
15. Zhu J, Mayeda A, Krainer AR. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol Cell 2001; 8:1351-61. (Pubitemid 34086947)
16. Jablonski JA, Caputi M. Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication and infectivity. J Virol 2009; 83:981-92.
17. Saliou JM, Bourgeois CF, Ayadi-Ben Mena L, Ropers D, Jacquenet S, Marchand V, et al. Role of RNA structure and protein factors in the control of HIV-1 splicing. Front Biosci 2009; 14:2714-29.
18. Tange TO, Kjems J. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. J Mol Biol 2001; 312:649-62. (Pubitemid 33120935)
19. Mayeda A, Screaton GR, Chandler SD, Fu XD, Krainer AR. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol Cell Biol 1999; 19:1853-63.
20. Okunola HL, Krainer AR. Cooperative-binding and splicing-repressive properties of hnRNP A1. Mol Cell Biol 2009; 29:5620-31.
21. Woolaway K, Asai K, Emili A, Cochrane A. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression. Retrovirology 2007; 4:28.
22. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW Jr, Swanstrom R, et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009; 460:711-6.
23. Hartmuth K, Vornlocher HP, Luhrmann R. Tobramycin affinity tag purification of spliceosomes. Methods Mol Biol 2004; 257:47-64.
24. Jurica MS, Licklider LJ, Gygi SR, Grigorieff N, Moore MJ. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 2002; 8:426-39. (Pubitemid 34437714)
25. Deckert J, Hartmuth K, Boehringer D, Behzadnia N, Will CL, Kastner B, et al. Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions. Mol Cell Biol 2006; 26:5528-43. (Pubitemid 44036218)
26. Hamasaki K, Killian J, Cho J, Rando RR. Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities. Biochemistry 1998; 37:656-63. (Pubitemid 28123799)
27. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007; 17:80-6. (Pubitemid 46199181)
28. Allain FH, Bouvet P, Dieckmann T, Feigon J. Molecular basis of sequence-specific recognition of pre-ribosomal RNA by nucleolin. EMBO J 2000; 19:6870-81. (Pubitemid 32011680)
29. Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays 2004; 26:629-38. (Pubitemid 38758340)
30. Fisette JF, Toutant J, Dugre-Brisson S, Desgroseillers L, Chabot B. hnRNP A1 and hnRNP H can collaborate to modulate 5′ splice site selection. RNA 2009; 16:228-38.
31. Schaub MC, Lopez SR, Caputi M. Members of the heterogeneous nuclear ribonucleoprotein H family activate splicing of an HIV-1 splicing substrate by promoting formation of ATP-dependent spliceosomal complexes. J Biol Chem 2007; 282:13617-26. (Pubitemid 47100498)
32. Belenguer P, Caizergues-Ferrer M, Labbe JC, Doree M, Amalric F. Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase. Mol Cell Biol 1990; 10:3607-18.
33. Bouvet P, Allain FH, Finger LD, Dieckmann T, Feigon J. Recognition of pre-formed and flexible elements of an RNA stem-loop by nucleolin. J Mol Biol 2001; 309:763-75. (Pubitemid 32595107)
34. Ginisty H, Amalric F, Bouvet P. Two different combinations of RNA-binding domains determine the RNA binding specificity of nucleolin. J Biol Chem 2001; 276:14338-43.
35. Serin G, Joseph G, Ghisolfi L, Bauzan M, Erard M, Amalric F, Bouvet P. Two RNA-binding domains determine the RNA-binding specificity of nucleolin. J Biol Chem 1997; 272:13109-16. (Pubitemid 27216734)
36. Jacquenet S, Ropers D, Bilodeau PS, Damier L, Mougin A, Stoltzfus CM, Branlant C. Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3′ splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucl Acids Res 2001; 29:464-78. (Pubitemid 32060933)
37. Caputi M, Zahler AM. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H′/F/2H9 family. J Biol Chem 2001; 276:43850-9.
38. Expert-Bezançon A, Le Caer JP, Marie J. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA. J Biol Chem 2002; 277:16614-23. (Pubitemid 34967679)
39. Ropers D, Ayadi L, Gattoni R, Jacquenet S, Damier L, Branlant C, Stevenin J. Differential effects of the SR proteins 9G8, SC35, ASF/SF2 and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J Biol Chem 2004; 279:29963-73. (Pubitemid 38937916)
40. Jacquenet S, Decimo D, Muriaux D, Darlix JL. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2005; 2:33.
41. Ginisty H, Serin G, Ghisolfi-Nieto L, Roger B, Libante V, Amalric F, Bouvet P. Interaction of nucleolin with an evolutionarily conserved pre-ribosomal RNA sequence is required for the assembly of the primary processing complex. J Biol Chem 2000; 275:18845-50. (Pubitemid 30422847)
42. Finger LD, Johansson C, Rinaldi B, Bouvet P, Feigon J. Contributions of the RNA-binding and linker domains and RNA structure to the specificity and affinity of the nucleolin RBD12/NRE interaction. Biochemistry 2004; 43:6937-47. (Pubitemid 38720512)
43. Ginisty H, Sicard H, Roger B, Bouvet P. Structure and functions of nucleolin. J Cell Sci 1999; 112:761-72. (Pubitemid 29179310)
44. Nisole S, Krust B, Hovanessian AG. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp Cell Res 2002; 276:155-73. (Pubitemid 34969310)
45. Cochrane AW, Perkins A, Rosen CA. Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J Virol 1990; 64:881-5. (Pubitemid 20032706)
46. Michienzi A, Cagnon L, Bahner I, Rossi JJ. Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA. Proc Natl Acad Sci USA 2000; 97:8955-60. (Pubitemid 30626655)
47. Bacharach E, Gonsky J, Alin K, Orlova M, Goff SP. The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly. J Virol 2000; 74:11027-39. (Pubitemid 32223968)
48. Ueno T, Tokunaga K, Sawa H, Maeda M, Chiba J, Kojima A, et al. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol Immunol 2004; 48:111-8. (Pubitemid 38248337)
49. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev 2000; 14:1236-48. (Pubitemid 30327504)
50. Huang Y, Huang K, Boskovic G, Dementieva Y, Denvir J, Primerano DA, Zhu GZ. Proteomic and genomic analysis of PITX2 interacting and regulating networks. FEBS Lett 2009; 583:638-42.
51. Borggrefe T, Wabl M, Akhmedov AT, Jessberger R. A B-cell-specific DNA recombination complex. J Biol Chem 1998; 273:17025-35. (Pubitemid 28311736)
52. Nicol SM, Fuller-Pace FV. Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator. Methods Mol Biol 2010; 587:265-79.
53. Kim JH, Hahm B, Kim YK, Choi M, Jang SK. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm. J Mol Biol 2000; 298:395-405.
54. Griffith BN, Walsh CM, Szeszel-Fedorowicz W, Timperman AT, Salati LM. Identification of hnRNPs K, L and A2/B1 as candidate proteins involved in the nutritional regulation of mRNA splicing. Biochim Biophys Acta 2006; 1759:552-61. (Pubitemid 46054231)
55. Revil T, Pelletier J, Toutant J, Cloutier A, Chabot B. Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform. J Biol Chem 2009; 284:21458-67.
56. Wolf D, Witte V, Clark P, Blume K, Lichtenheld MG, Baur AS. HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex. Cell Host Microbe 2008; 4:398-408.
57. Yang JP, Reddy TR, Truong KT, Suhasini M, Wong- Staal F. Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K. Oncogene 2002; 21:7187-94. (Pubitemid 35305605)
58. Reddy TR, Xu W, Mau JK, Goodwin CD, Suhasini M, Tang H, et al. Inhibition of HIV replication by dominant negative mutants of Sam68, a functional homolog of HIV-1. Rev Nat Med 1999; 5:635-42. (Pubitemid 29289426)
59. McLaren M, Cochrane A. Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68. Virology 2009; 385:93-104.
60. Mikula M, Dzwonek A, Karczmarski J, Rubel T, Dadlez M, Wyrwicz LS, et al. Landscape of the hnRNP K protein-protein interactome. Proteomics 2006; 6:2395-406.
61. Chen HC, Lin WC, Tsay YG, Lee SC, Chang CJ. An RNA helicase, DDX1, interacting with poly(A) RNA and heterogeneous nuclear ribonucleoprotein K. J Biol Chem 2002; 277:40403-9.
62. Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004; 330:471-80. (Pubitemid 39572852)
63. Zhang S, Schlott B, Gorlach M, Grosse F. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucl Acids Res 2004; 32:1-10. (Pubitemid 38228598)
64. Li J, Tang H, Mullen TM, Westberg C, Reddy TR, Rose DW, Wong-Staal F. A role for RNA helicase A in post-transcriptional regulation of HIV type 1. Proc Natl Acad Sci USA 1999; 96:709-14. (Pubitemid 29061273)
65. Ting NS, Kao PN, Chan DW, Lintott LG, Lees-Miller SP. DNA-dependent protein kinase interacts with antigen receptor response element binding proteins NF90 and NF45. J Biol Chem 1998; 273:2136-45. (Pubitemid 28069263)
66. Maenner S, Blaud M, Fouillen L, Savoye A, Marchand V, Dubois A, et al. 2-D structure of the A region of Xist RNA and its implication for PRC2 association. PLoS Biol 2010; 8:1000276.
67. Chou MY, Rooke N, Turck CW, Black DL. hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Mol Cell Biol 1999; 19:69-77. (Pubitemid 29018410)
68. Hallay H. Study on the mechanisms of alternative splicing of the RNA from the human immunodeficiency virus 1: Binding and mechanism of action of hnRNP and SR proteins at the A3 acceptor site. Ph.D., Thesis, Vandoeuvre-les-Nancy: H. Poincaré University 2006.
69. Bourgeois CF, Popielarz M, Hildwein G, Stevenin J. Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5′ or 3′ splice site activation. Mol Cell Biol 1999; 19:7347-56. (Pubitemid 29493398)
70. Miguet L, Bechade G, Fornecker L, Zink E, Felden C, Gervais C, et al. Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. J Proteome Res 2009; 8:3346-54.
71. De Vos RC, Moco S, Lommen A, Keurentjes JJ, Bino RJ, Hall RD. Untargeted large-scale plant metabolomics using liquid chromatography coupled to mass spectrometry. Nat Protoc 2007; 2:778-91. (Pubitemid 46745574)
72. Damier L, Domenjoud L, Branlant C. The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site. Biochem Biophys Res Commun 1997; 237:182-7. (Pubitemid 27390348)